Risks and uncertainties include, but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and healthcare legislation in the United States and internationally; global trends toward healthcare cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
From what I read of it it sounded like a really intriguing herb and a great cheap option for people with pain. Pain relief is a huge chunk of the prescription market in my country, and for sure something like this is a threat to big pharma revenue streams, even though those revenue streams are massive, the greedy fucks don’t like non patented competition. I expect you will start seeing media articles from the govt trying to talk up the negative health risks and cost to society of kratom use using a couple of individual cases. There was 1 death from Kava (guy took a huge amount) in my country and that was enough for the govt to quickly ban it despite its previous safe history and not worrying about the fact that thousands die each year from prescription meds or hospital errors.